Current therapeutic options and development strategies in cancer immunotherapy

The increase in knowledge about the way the immune system functions is leading to exciting new therapeutic possibilities for cancer patients. A panel of experts met during the ESMO Symposium on Immuno-Oncology to discuss: Critical components of immune therapy; Disruption of homeostatic regulatory mechanisms; Angiogenesis blockade; Expansion of tumour-reactive T cells. Read the panel discussion here.